Literature DB >> 18712282

Diagnosis of malignant glioma: role of neuropathology.

Daniel J Brat1, Richard A Prayson, Timothy C Ryken, Jeffrey J Olson.   

Abstract

Entities:  

Mesh:

Year:  2008        PMID: 18712282     DOI: 10.1007/s11060-008-9618-1

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


× No keyword cloud information.
  106 in total

1.  Alterations of chromosome arms 1p and 19q as predictors of survival in oligodendrogliomas, astrocytomas, and mixed oligoastrocytomas.

Authors:  J S Smith; A Perry; T J Borell; H K Lee; J O'Fallon; S M Hosek; D Kimmel; A Yates; P C Burger; B W Scheithauer; R B Jenkins
Journal:  J Clin Oncol       Date:  2000-02       Impact factor: 44.544

2.  The presence of necrosis and/or microvascular proliferation does not influence survival of patients with anaplastic oligodendroglial tumours: review of 98 patients.

Authors:  Sarah F Smith; Judy M Simpson; Janice A Brewer; Lali H S Sekhon; Michael T Biggs; Raymond J Cook; Nicholas S Little
Journal:  J Neurooncol       Date:  2006-06-23       Impact factor: 4.130

3.  Prognosis research: toward evidence-based results and a Cochrane methods group.

Authors:  Richard D Riley; Greta Ridley; Katrina Williams; Douglas G Altman; Jill Hayden; Henrica C W de Vet
Journal:  J Clin Epidemiol       Date:  2007-06-06       Impact factor: 6.437

Review 4.  Diagnostic synergy in radiology and surgical neuropathology: neuroimaging techniques and general interpretive guidelines.

Authors:  P C Burger; J S Nelson; O B Boyko
Journal:  Arch Pathol Lab Med       Date:  1998-07       Impact factor: 5.534

5.  Keratin expression in astrocytomas: an immunofluorescent and biochemical reassessment.

Authors:  V K Kriho; H Y Yang; J R Moskal; O Skalli
Journal:  Virchows Arch       Date:  1997-08       Impact factor: 4.064

6.  Intermediate filament expression in astrocytic neoplasms.

Authors:  M Cosgrove; P L Fitzgibbons; A Sherrod; P T Chandrasoma; S E Martin
Journal:  Am J Surg Pathol       Date:  1989-02       Impact factor: 6.394

7.  Grading of astrocytomas. A simple and reproducible method.

Authors:  C Daumas-Duport; B Scheithauer; J O'Fallon; P Kelly
Journal:  Cancer       Date:  1988-11-15       Impact factor: 6.860

8.  Reliability of histological diagnosis including grading in gliomas biopsied by image-guided stereotactic technique.

Authors:  T Revesz; F Scaravilli; L Coutinho; H Cockburn; P Sacares; D G Thomas
Journal:  Brain       Date:  1993-08       Impact factor: 13.501

9.  Optimization of quantitative MGMT promoter methylation analysis using pyrosequencing and combined bisulfite restriction analysis.

Authors:  Thomas Mikeska; Christoph Bock; Osman El-Maarri; Anika Hübner; Denise Ehrentraut; Johannes Schramm; Jörg Felsberg; Philip Kahl; Reinhard Büttner; Torsten Pietsch; Andreas Waha
Journal:  J Mol Diagn       Date:  2007-07       Impact factor: 5.568

10.  Necrosis as a prognostic factor in glioblastoma multiforme.

Authors:  F G Barker; R L Davis; S M Chang; M D Prados
Journal:  Cancer       Date:  1996-03-15       Impact factor: 6.860

View more
  38 in total

1.  Nature versus nurture in glioblastoma: microenvironment and genetics can both drive mesenchymal transcriptional signature.

Authors:  Brent A Orr; Charles G Eberhart
Journal:  Am J Pathol       Date:  2012-03-23       Impact factor: 4.307

Review 2.  Management of newly diagnosed glioblastoma: guidelines development, value and application.

Authors:  Jeffrey J Olson; Camilo E Fadul; Daniel J Brat; Srinivasan Mukundan; Timothy C Ryken
Journal:  J Neurooncol       Date:  2009-05-09       Impact factor: 4.130

3.  Glioblastoma stem cells are regulated by interleukin-8 signaling in a tumoral perivascular niche.

Authors:  David W Infanger; YouJin Cho; Brina S Lopez; Sunish Mohanan; S Chris Liu; Demirkan Gursel; John A Boockvar; Claudia Fischbach
Journal:  Cancer Res       Date:  2013-10-11       Impact factor: 12.701

4.  MRI-guided 3D conformal arc micro-irradiation of a F98 glioblastoma rat model using the Small Animal Radiation Research Platform (SARRP).

Authors:  Julie Bolcaen; Benedicte Descamps; Karel Deblaere; Tom Boterberg; Giorgio Hallaert; Caroline Van den Broecke; Elke Decrock; Anne Vral; Luc Leybaert; Christian Vanhove; Ingeborg Goethals
Journal:  J Neurooncol       Date:  2014-07-29       Impact factor: 4.130

5.  The tumor microenvironment strongly impacts master transcriptional regulators and gene expression class of glioblastoma.

Authors:  Lee A D Cooper; David A Gutman; Candace Chisolm; Christina Appin; Jun Kong; Yuan Rong; Tahsin Kurc; Erwin G Van Meir; Joel H Saltz; Carlos S Moreno; Daniel J Brat
Journal:  Am J Pathol       Date:  2012-03-20       Impact factor: 4.307

6.  Clinical practice guidelines in the AANS/CNS Section on Tumors: past, present and future directions.

Authors:  Mark E Linskey; Jeffrey J Olson; Laura S Mitchell; Steven N Kalkanis
Journal:  J Neurooncol       Date:  2014-08-01       Impact factor: 4.130

7.  The TRPC channel blocker SKF 96365 inhibits glioblastoma cell growth by enhancing reverse mode of the Na(+) /Ca(2+) exchanger and increasing intracellular Ca(2+).

Authors:  M Song; D Chen; S P Yu
Journal:  Br J Pharmacol       Date:  2014-07       Impact factor: 8.739

8.  Effects of hnRNP A2/B1 Knockdown on Inhibition of Glioblastoma Cell Invasion, Growth and Survival.

Authors:  Jinmu Deng; Song Chen; Feng Wang; Hongxin Zhao; Zongyi Xie; Zhongye Xu; Qingtao Zhang; Ping Liang; Xuan Zhai; Yuan Cheng
Journal:  Mol Neurobiol       Date:  2015-01-14       Impact factor: 5.590

Review 9.  The biology and mathematical modelling of glioma invasion: a review.

Authors:  J C L Alfonso; K Talkenberger; M Seifert; B Klink; A Hawkins-Daarud; K R Swanson; H Hatzikirou; A Deutsch
Journal:  J R Soc Interface       Date:  2017-11       Impact factor: 4.118

10.  Acute ischemic stroke secondary to glioblastoma. A case report.

Authors:  Sofia Pina; Ângelo Carneiro; Tiago Rodrigues; Raquel Samões; Ricardo Taipa; Manuel Melo-Pires; Cláudia Pereira
Journal:  Neuroradiol J       Date:  2014-02-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.